Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia (original) (raw)

References

  1. Rabbits, T.H. Chromosomal translocations in human cancer. Nature 372, 143–149 (1994).
    Article Google Scholar
  2. Wolff, L. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochim. Biophys. Acta 1332, F67–104 (1997).
    CAS PubMed Google Scholar
  3. Tenen, D.G., Hromas, R., Licht, J.D. & Zhang, D.E. Transcription factors, normal myeloid development, and leukemia. Blood 90, 489–519 (1997).
    CAS Google Scholar
  4. Landschulz, W.H., Johnson, P.F., Adashi, E.Y., Graves, B.J. & McKnight, S.L. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev. 2, 786–800 (1988).
    Article CAS Google Scholar
  5. Cao, Z., Umek, R.M. & McKnight, S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5, 1538–1552 (1991).
    Article CAS Google Scholar
  6. Lin, F.T. & Lane, M.D. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA 91, 8757–8761 (1994).
    Article CAS Google Scholar
  7. Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R. & Darlington, G.J. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10, 804–815 (1996).
    Article CAS Google Scholar
  8. Watkins, P.J., Condreay, J.P., Huber, B.E., Jacobs, S.J. & Adams, D.J. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Res. 56, 1063–1067 (1996).
    CAS PubMed Google Scholar
  9. Umek, R.M., Friedman, A.D. & McKnight, S.L. CCAAT/enhancer binding protein α: a component of a differentiation switch. Science 251, 288–292 (1991).
    Article CAS Google Scholar
  10. Hendricks-Taylor, L.R. & Darlington, G.J. Inhibition of cell proliferation by C/EBPα occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res. 23, 4726–4733 (1995).
    Article CAS Google Scholar
  11. Scott, L.M., Civin, C.I., Roth, P. & Friedman, A.D. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80, 1725–1735 (1992).
    CAS PubMed Google Scholar
  12. Radomska, H.S. et al. CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18, 4301–4314 (1998).
    Article CAS Google Scholar
  13. Zhang, D.E. et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94, 569–574 (1997).
    Article CAS Google Scholar
  14. An, M.R. et al. Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during the lipopolysaccharide-mediated acute-phase response. Mol. Cell. Biol. 16, 2295–2306 (1996).
    Article CAS Google Scholar
  15. Calkhoven, C.F., Bouwman, P.R.J., Snippe, L. & Ab, G. Translation start site multiplicity of the CCAAT/enhancer binding protein α mRNA is dictated by a small 5′ open reading frame. Nucleic Acids Res. 22, 5540–5547 (1994).
    Article CAS Google Scholar
  16. Ossipow, V., Descombes, P. & Schibler, U. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA 90, 8219–8223 (1993).
    Article CAS Google Scholar
  17. Smith, L.T., Hohaus, S., Gonzalez, D.A., Dziennis, S.E. & Tenen, D.G. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88, 1234–1247 (1996).
    CAS PubMed Google Scholar
  18. Koike, M. et al. C/EBP-ɛ: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia. Leuk. Res. 21, 833–839 (1997).
    Article CAS Google Scholar
  19. Yamanaka, R. et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein ɛ-deficient mice. Proc. Natl. Acad. Sci. USA 94, 13187–13192 (1997).
    Article CAS Google Scholar
  20. Lekstrom-Himes, J.A., Dorman, S.E., Kopar, P., Holland, S.M. & Gallin, J.I. Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein ɛ. J. Exp. Med. 189, 1847–1852 (1999).
    Article CAS Google Scholar
  21. Lekstrom-Himes, J.A. & Xanthopoulos, K.G. CCAAT/enhancer binding protein ɛ is critical for effective neutrophil-mediated response to inflammatory challenge. Blood 93, 3096–3105 (1999).
    CAS PubMed Google Scholar
  22. Osato, M. et al. Biallelic and heterozygous point mutations in the Runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias. Blood 93, 1817–1824 (1998).
    Google Scholar
  23. Kozak, M. The scanning model for translation: an update. J. Cell Biol. 108, 229–241 (1989).
    Article CAS Google Scholar
  24. Descombes, P. & Schibler, U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569–579 (1991).
    Article CAS Google Scholar
  25. Lin, F.T., MacDougald, O.A., Diehl, A.M. & Lane, M.D. A 30-kD alternative translation product of the CCAAT/enhancer binding protein α message: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA 90, 9606–9610 (1993).
    Article CAS Google Scholar
  26. Hendricks-Taylor, L.R. & Darlington, G.J. The CCAAT/enhancer-binding protein (C/EBP α) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP β) gene (CEBPB) gene maps to human chromosome 20q13.1. Genomics 14, 12–17 (1992).
    Article CAS Google Scholar
  27. Westendorf, J.J. et al. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol. 18, 322–333 (1998).
    Article CAS Google Scholar
  28. Swart, G.W.M., van Groningen, J.J.M., van Ruissen, F., Bergers, M. & Schalkwijk, J. Transcription factor C/EBPα: novel sites of expression and cloning of the human gene. Biol. Chem. 378, 373–379 (1997).
    Article CAS Google Scholar
  29. Pahl, H.L., Burn, T.C. & Tenen, D.G. Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Exp. Hematol. 19, 1038–1041 (1991).
    CAS PubMed Google Scholar
  30. Nerlov, C. & Ziff, E.B. Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-α on the serum albumin promoter. Genes Dev. 8, 350–362 (1994).
    Article CAS Google Scholar
  31. Friedman, A.D. & McKnight, S.L. Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. Genes Dev. 4, 1416–1426 (1990).
    Article CAS Google Scholar
  32. Landschulz, W.H., Johnson, P.F. & McKnight, S.L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759–1764 (1988).
    Article CAS Google Scholar

Download references